ACE Report Cover
Multi-injection HA appears to be more effective than single-injection HA versus saline for knee OA
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
OSTEOARTHRITIS
Multi-injection HA appears to be more effective than single-injection HA versus saline for knee OA .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2018;6(2):8 BMC Musculoskelet Disord. 2017 Dec 21;18(1):542
Autori che hanno contribuito

P Sancheti A Concoff F Niazi P Shaw J Rosen

30 blinded randomized controlled trials evaluating the use of hyaluronic acid injections in comparison to a placebo injection in patients with knee osteoarthritis were included in this systematic review and meta-analysis. The objective of this systematic review and meta-analysis was to compare the efficacy and safety of hyaluronic acid injections across different dosing regimens. At 3 months, data were available for 2-4 injection and 5+ injection groups. The 2-4 injection groups demonstrated significantly lower pain scores compared placebo (SMD -0.76 p<0.00001), while the 5+ injection groups did not demonstrate significantly lower pain compared to placebo (SMD -0.20; p=0.09). At 6 months, both the 2-4 injection group (SMD -0.36; p=0.008) and 5+ injection group demonstrated significantly lower pain compared to placebo (SMD -0.18; p=0.04). The single injection groups did not significantly reduce pain compared to placebo at 6 months (SMD -0.04; p=0.67). When looking at the incidence of adverse events, only the 5+ injection group demonstrated a significantly greater incidence compared to placebo (RR 1.67; p=0.02).


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Industry funded
Sponsor:
Ferring Pharmaceuticals
Conflicts:
Company Employee

Rischio di pregiudizio

10/10

Criteri di segnalazione

19/20

Indice di fragilità

N/A

Were the search methods used to find evidence (original research) on the primary question or questions stated?

Was the search for evidence reasonably comprehensive?

Were the criteria used for deciding which studies to include in the overview reported?

Was the bias in the selection of studies avoided?

Were the criteria used for assessing the validity of the included studies reported?

Was the validity of all of the studies referred to in the text assessed with use of appropriate criteria (either in selecting the studies for inclusion or in analyzing the studies that were cited)?

Were the methods used to combine the findings of the relevant studies (to reach a conclusion) reported?

Were the findings of the relevant studies combined appropriately relative to the primary question that the overview addresses?

Were the conclusions made by the author or authors supported by the data and or analysis reported in the overview?

How would you rate the scientific quality of this evidence?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

4/4

Introduction

4/4

Accessing Data

4/4

Analysing Data

3/4

Results

4/4

Discussion

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

Injection therapies are a prominent topic in research of knee osteoarthritis treatment. Viscosupplementation with intra-articular injection of hyaluronic acid remains one of the most researched and controversial methods of treatment. There is a debate as to whether the number of HA injections administered significantly influences efficacy.

Qual era la domanda di ricerca principale?

In the treatment of knee osteoarthritis, is there a significant difference in effect on pain between single injection, 2-4 injection, and 5+ injection protocols when compared to placebo saline?

Caratteristiche dello studio +
Data Source:
MEDLINE, EMBASE, and PubMed were searched for relevant articles published up to February 26, 2016.
Index Terms:
Full search strategies for each database can be found in the online appendix of the full publication.
Study Selection:
Eligibility criteria included: a randomized controlled trial design; allocation of patients to the administration of either intra-articular hyaluronic acid or intra-articular saline; blinded administration and assessment; reported outcome related to pain; and published in English. Search and selection were performed in duplicate.
Data Extraction:
Data extraction was performed by one reviewer, and cross-checked for accuracy by a second reviewer.
Data Synthesis:
Statistical analyses were performed using Review Manager software (RevMan 5.3). Standardized mean differences were calculated for continuous outcomes (ie. pain), with 95% confidence intervals. Risk ratios were calculated for dichotomous outcomes, with 95% confidence intervals. Analyses were categorized by the number of injections administered, either as 1 injection, 2-4 injections, or 5+ injections.
Quali erano i risultati importanti?
  • Only data on 2-4 injection and 5+ injection groups were available at 3 months. The 2-4 injection groups demonstrated significantly lower pain scores compared placebo (6 studies; SMD -0.76 [95%CI -0.98, -0.53]; p<0.00001), but 5+ injection groups did not demonstrate significantly lower pain compared to placebo (3 studies; SMD -0.20 [95%CI -0.43, 0.03]; p=0.09).
  • At 6 months, 2-4 injection groups (10 studies; SMD -0.36 [95%CI -0.63, -0.09]; p=0.008) and 5+ injection groups demonstrated significantly lower pain compared to placebo (6 studies; SMD -0.18 [95%CI -0.35, -0.01]; p=0.04); single injection groups did not significantly differ in pain scores to placebo (2 studies; SMD -0.04 [95%CI -0.20, 0.13]; p=0.67).
  • The incidence of adverse events did not significantly differ between 1 injection groups and placebo (4 studies; RR 1.22 [95%CI 0.85, 1.75]; p=0.28), and 2-4 injection groups and placebo (4 studies; RR 0.97 [95%CI 0.86, 1.08]; p=0.57); 5+ injection groups demonstrated a significantly higher incidence of adverse events compared to placebo (5 studies; RR 1.67 [95%CI 1.09, 2.56]; p=0.02).
Che cosa devo ricordare di più?

In knee osteoarthritis treatment, two to four IA HA injections demonstrated effective pain reduction compared to placebo at 3 and 6 months, without a significant increase in the rate of adverse events. Single IA HA injection did not reduce pain compared to placebo after 6 months, and while five or more IA HA injections demonstrated significant pain reduction compared to placebo at 6 months, they were also associated with a significantly greater incidence of adverse events.

Come influenzerà l'assistenza ai miei pazienti?

The results of this study suggest that, currently, the most optimal IA HA injection protocol for knee osteoarthritis is 2-4 injections, given the balance between both efficacy and safety measures. Nonetheless, direct comparisons are required between different numbers of injections, as well as on subgroups of particular IA HA product characteristics, such as molecular weight and crosslinking.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. Multi-injection HA appears to be more effective than single-injection HA versus saline for knee OA. OE Journal. 2018;6(2):8. Available from: https://myorthoevidence.com/AceReport/Show/multi-injection-ha-appears-to-be-more-effective-than-single-injection-ha-versus-saline-for-knee-oa

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report